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Breast cancer is the most common cancer and the incidence and mortality rate 
had remained high. In Malaysia alone, breast cancers accounted for 31% of all 
new cancer cases and are among the most fatal cancers.  Since breast cancers 
are complex diseases, there is no single marker that is both sensitive and 
specific for early detection of the disease.  The present study was undertaken to 
characterize rat mammary gland tumors as a model for breast cancers and to 
determine parameters that could be used as early tumor markers. The study 
also undertook to determine the effect of recombinant human erythropoietin 
(rHuEPO) and Tamoxifen on the rat mammary gland tumor. 
 
In the first part of the study serum biochemical parameters, angiogenic factors 
and tumor markers, tumor histopathology and ultrastructure and expression of 
estrogen (ER) and erythropoietin receptors (EPOR) were determined. Twenty 
female Sprague-Dawley rats, aged six to seven weeks were divided into two 
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groups of 10 rats per group. The rats were treated intragastrically, the first 
group with 20 mg 7,12-dimethylbenz(a)anthracene (DMBA) per rat to induce 
mammary tumor development and the second group with 1 mL 0.9% normal 
saline and served as the control. The animals were palpated weekly for tumor 
mass and sacrificed two weeks after tumor occurrence. Blood was withdrawn 
through cardiac puncture before tumor induction and weekly thereafter. Serum 
biochemical parameters analysed were alkaline phosphatase (ALP), aspartate 
aminotransferase (AST), alanine transferase (ALT), lactate dehydrogenase 
(LDH), creatinine kinase (CK), glucose, blood urea nitrogen (BUN) and 
creatinine by a chemistry analyser using standard diagnostic kits. Serum tumor 
markers,namely α-fetoprotein (AFP) and CA15-3 were analysed using 
automated immunoassay analyser, while the angiogenic factors, matrix 
metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) 
were determined by the ELISA technique. Tumor tissues excised from 
sacrificed animals were subjected to histopathological analysis and ER-α and 
EPOR determination through immunohistochemistry (IHC). Tumor ultrastructure 
was examined by transmission electron microscopy (TEM).  
 
The results showed higher ALT, ALP and AST concentrations in the DMBA-
treated than the control group reflecting abnormal liver function. Pronounced 
increases in serum LDH were also observed in the DMBA-treated group. 
Angiogenic factor estimations showed that serum MMP-2 levels remained high 
throughout the study and seemed to have played a greater role than VEGF in 
 v
early stage tumorigenesis. Serum tumor markers, AFP and CA 15.3 were not 
detected in either the treated or control rats. Histopathological analysis showed 
features typical of neoplastic cells which were enlarged nuclei, conspicuous 
nucleoli nuclear pleomorphism, high nuclear to cytoplasma ratio, 
hyperchromasia, and epithelial cell and stroma hyperplasia. These features are 
similar to that found in breast cancers.  Immunohistochemical analysis showed 
that ER-α and EPOR were present in the DMBA-induced rat mammary tumor, 
which also resemble human breast cancers. Transmission electron microscopy 
analysis of the tumor demonstrated the co-existence of apoptosis, necrosis and 
aponecrosis which may be used in the determination of mammary gland tumor 
and breast cancer development in the early stages.  
 
In conclusion, the combination of serum liver-related enzymes, serum MMP-2 
and histological changes, ER-α and EPOR expression, evidences of apoptosis, 
necrosis and aponecrosis may form the panel for screening and determination 
of early mammary gland tumors in high risk cancer patients. 
 
The second phase of the study involved the development of a xenograft-
induced mammary gland tumor model in rats as a substitute for the 
conventional drug-induced method. The xenograft-induced mammary gland 
tumor seems to be reliable and can produce tumors within a short period. The 
xenograft model was then used to evaluate the effects of rHuEPO, Tamoxifen 
and Tamoxifen-rHuEPO combination on mammary gland tumor growth and 
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angiogenesis. In this study, 24 rats were divided into four groups of six rats 
each. Each rat was treated orally: Group 1 with 60 IU rHuEPO; Group 2 with 20 
mg Tamoxifen; Group 3 with a combination of 20 mg Tamoxifen and 60 IU 
rHuEPO; Group 4 with 1 mL 0.9% normal saline and served as the control. The 
results showed that rHuEPO did not promote mammary tumor growth and in 
fact may enhance the cytotoxicity of Tamoxifen through the stimulation of 
proapoptotic and antiproliferative effects. This study suggests that rHuEPO 
treatment in cancer patients may not only be beneficial for the alleviation of 
anemia due to the disease, but also augments the effect of certain 
chemotherapeutic drugs used in the treatment of cancers. 
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Kanser payudara merupakan kanser yang sangat biasa berlaku dan kadar 
insidens dan kematiannya kekal tinggi. Di Malaysia sahaja, kanser payudara 
menyumbang sebanyak 31% kepada kes baru kanser dan merupakan kanser 
yang paling banyak menyebabkan kematian. Memandangkan kanser payudara 
adalah penyakit yang kompleks, tiada satu petanda tunggal yang peka dan 
khusus untuk pengesanan awal penyakit ini. Kajian ini telah diambil untuk 
mencirikan tumor kelenjar mama tikus sebagai model untuk kanser payudara 
and menentukan parameter yang boleh digunakan sebagai petanda awal 
tumor.  Kajian ini juga telah dijalankan bagi menentukan kesan eritropoietin 
manusia rekombinan (rHuEPO) dan Tamoxifen terhadap tumor kelenjar mama 
tikus. 
 
Di dalam bahagian pertama kajian, parameter biokimia serum, faktor 
angiogenesis dan petanda tumor, histopatologi tumor dan ultrastruktur dan 
pernyataan reseptor estrogen (ER) dan eritropoietin (EPOR) telah ditentukan. 
Di dalam kajian ini, 20 ekor tikus betina Sprague-Dawley, berumur 6 hingga 7 
minggu telah dibahagikan kepada dua kumpulan terdiri daripada 10 ekor tikus 
setiap kumpulan. Tikus-tikus ini diperlakukan secara intragaster, kumpulan 
pertama dengan 20 mg 7,12-dimetilbenz(a)antrasin (DMBA) setiap ekor untuk 
mengaruhkan pembentukan tumor dan kumpulan kedua diberi 1 mL 0.9% 
larutan salina normal dan bertindak sebagai kumpulan kawalan. Haiwan 
dipalpatkan setiap minggu untuk pengesanan tumor dan dimusnahkan dua 
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minggu selepas kejadian tumor. Darah diambil secara tusukan jantung sebelum 
pembentukan tumor diaruhkan dan setiap minggu seterusnya. Parameter 
biokimia serum yang dianalisis ialah alkalin fosfatase (ALP), aspartat 
aminotransefase (AST), alanin transferase (ALT), laktat dehidrogenase (LDH), 
glukosa, urea nitrogen darah (BUN) dan kreatinin secara penganalisis kimia 
dan kit diagnostik standard. Petanda tumor serum, α-fetoprotein (AFP) dan CA 
15.3 telah dianalisis menggunakan penganalisis immunoassai automatik, 
sementara faktor angiogenesis, matrik metalloproteinase-2 (MMP-2) dan faktor 
pertumbuhan endotelium vesel (VEGF) telah ditentukan menggunakan teknik 
ELISA. Pada tisu tumor yang diambil dari haiwan yang dimusnahkan, dilakukan 
analisis histopatologi dan penentuan reseptor ER-α dan EPOR secara 
immunohistokimia (IHC). Ultrastruktur tumor telah diperiksa menggunakan 
mikroskop elektron transmisi (TEM). 
Keputusan kajian menunjukkan kepekatan ALT, ALP dan AST lebih tinggi 
dalam tikus kumpulan DMBA-diperlaku berbanding kumpulan kawalan, 
mencerminkan keabnormalan fungsi hati. Peningkatan nyata LDH serum 
diperhatikan dalam kumpulan DMBA-diperlaku. Penganggaran faktor 
angiogenesis menunjukkan bahawa paras MMP-2 serum kekal tinggi 
sepanjang kajian dan nampaknya memain peranan lebih besar daripada VEGF 
pada peringkat awal tumorigenesis. Petanda tumor serum, AFP dan CA15.3 
tidak dikesan samada dalam tikus tumor kelenjar mama DMBA-teraruh atau 
kawalan. Analisis histopatologi menunjukkan sifat yang tipikal untuk sel 
neoplasia seperti nukleus besar, pleomorfisma nukleus ketara, nisbah nuklear 
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kepada sitoplasma tinggi, hiperkromasia dan hiperplasia sel epithelium dan 
stroma. Semua sifat ini menyerupai apa yang terdapat pada kanser payudara. 
Analisis immunohistokimia menunjukkan kehadiran ER-α dan EPOR pada 
tumor kelenjar mama DMBA-teraruh yang juga menyerupai kanser payudara 
manusia. Analisis elektron mikroskop transmisi terhadap tumor menunjukkan 
pewujudan bersama apoptosis, nekrosis dan aponekrosis yang mungkin boleh 
diguna dalam penentuan perkembangan tumor kelenjar mama dan kanser 
payudara peringkat awal. 
 
Sebagai kesimpulan, gabungan enzim berkaitan hati, MMP-2 serum dan 
perubahan histologi, pernyataan ER-α dan EPOR, bukti apoptosis, nekrosis dan 
aponekrosis mungkin boleh jadi panel bagi penyaringan dan penentuan untuk 
peringkat awal tumor kelenjar mama bagi pesakit-pesakit berisiko tinggi untuk 
kanser. 
 
Fasa kedua kajian ini melibatkan pembentukan tumor kelenjar mama xenograf-
teraruh pada tikus sebagai ganti kepada kaedah drug-teraruh biasa. Tumor 
kelenjar mama xenograf-teraruh adalah stabil dan penghasilan tumor berlaku 
dalam masa yang singkat. Model xenograf ini seterusnya digunakan untuk 
menilai kesan rHuEPO, Tamoxifen dan gabungan Tamoxifen-rHuEPO terhadap 
pertumbuhan tumor kelenjar mama dan angiogenesis. Dalam kajian ini, 24 ekor 
tikus dibahagikan kepada empat kumpulan terdiri daripada enam ekor setiap 
kumpulan. Setiap ekor tikus diperlakukan secara oral: Kumpulan 1 diberi 60 IU 
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rHuEPO; Kumpulan 2 diberi 20 mg Tamoxifen; Kumpulan 3 diberi gabungan  20 
mg Tamoxifen dan 60 IU rHuEPO; Kumpulan 4 diberi 1 mL 0.9% larutan salina 
normal dan bertindak sebagai kawalan. Keputusan kajian menunjukkan 
rHuEPO tidak menggalakan pertumbuhan tumor kelenjar mama malah mungkin 
meningkatkan lagi kesitotoksikan Tamoxifen melalui perangsangan kesan 
proapoptosis dan antiproliferatif. Kajian ini mencadangkan rawatan rHuEPO 
bagi pesakit kanser bukan hanya berfaedah untuk meringankan anemia 
disebabkan penyakit tersebut, tetapi juga memperkuatkan kesan kesitotoksikan 
beberapa drug kemoterapi tertentu yang diguna dalam rawatan kanser. 
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envelope convoluted and irregular. Heterochromatin is 
prominent at the perinuclear region (green arrow).     
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17 Mammary tumor tissue section from female rat shows 
swelling cell with relatively large nucleus and a 
prominent nucleolus (N). The cytoplasm contains 
numerous variable sized of vacuoles and defective 
cristae of mitochondria are noted (arrows).   
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18 Mammary tumor tissue from female rat showing bizarre 
nuclear shape with an indentation and the cytoplasm 
contains numerous cisternae rough endoplasmic 
reticulum (rER) (arrows).  
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19 Mammary tumor tissue from female rat showing a cell 
with very distinctive multiple nucleoli (N) and indented 
nuclear membrane (arrows).  
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